New Drug Application News and Research

RSS
Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

IMPAX receives final FDA approval for generic version of Sinemet CR

IMPAX receives final FDA approval for generic version of Sinemet CR

FDA approval of topical anti-inflammatory cream

FDA approval of topical anti-inflammatory cream

FDA knocks back King Pharmaceuticals self-injectible epilepsy product

FDA knocks back King Pharmaceuticals self-injectible epilepsy product

FDA approval for Cladribine to treat active Hairy Cell Leukemia

FDA approval for Cladribine to treat active Hairy Cell Leukemia

First generic cultivate(R) cream to receive tentative FDA approval

First generic cultivate(R) cream to receive tentative FDA approval

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

Schering-Plough submits Japanese application for hepatitis C drug

Schering-Plough submits Japanese application for hepatitis C drug

FDA approval for skin cancer cream

FDA approval for skin cancer cream

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

Genencor Sells Its Therapeutic Vaccine Program to Innogenetics

Genencor Sells Its Therapeutic Vaccine Program to Innogenetics

Oral chemotherapy agent Orathecin™ (rubitecan) capsules accepted by FDA for filing

Oral chemotherapy agent Orathecin™ (rubitecan) capsules accepted by FDA for filing

New drug to treat urinary tract infections, a step closer

New drug to treat urinary tract infections, a step closer